Danatlas Pharmaceuticals Co., Ltd.

Chine

Commandez votre montre hebdomadaire Danatlas Pharmaceuticals Co., Ltd.
Quantité totale PI 18
Rang # Quantité totale PI 85 244
Note d'activité PI 2,4/5.0    32
Rang # Activité PI 23 785

Brevets

Marques

1 0
1 0
16 0
0
 
Dernier brevet 2025 - Combination of polq inhibitor an...
Premier brevet 2022 - Tricyclic heterocyclic derivativ...

Derniers inventions, produits et services

2024 Invention Combination of polq inhibitor and anti-cancer therapeutic agent. Provided herein are combination ...
Invention Heterocyclic derivatives, compositions and uses thereof. The disclosure relates to heterocyclic d...
Invention Polq degraders, compositions and uses thereof. Provided are bifunctional compounds useful as modu...
Invention Cyclic derivatives, compositions and uses thereof. The disclosure relates to cyclic derivatives a...
Invention Tricyclic heterocyclic derivatives, compositions and uses thereof. The disclosure relates to tric...
Invention Thiadiazolone derivatives, compositions and uses thereof. The disclosure relates to thiadiazolone...
Invention Bicyclic derivatives, compositions and uses thereof. The disclosure relates to tricyclic heterocy...
2023 Invention Thiadiazolyl derivatives, compositions, and uses thereof. The disclosure relates to thiadiazolyl ...
Invention Thiadiazolyl derivatives, compositions and uses thereof. The disclosure relates to thiadiazolyl d...
Invention Tricyclic heterocyclic derivatives, compositions and uses thereof. The disclosure relates to tri...
Invention Tricyclic heterocyclic derivatives, compositions and uses thereof. Provided tricyclic heterocycli...
Invention Heterocyclic derivatives, compositions and uses thereof. Provided are heterocyclic derivatives as...
Invention Tricyclic heterocyclic derivatives, compositions and uses thereof